Sophia Genetics
Sophia Genetics Q3 Revenues Fall 3 Percent
Expected softness in its biopharma customer segment was buoyed by record analysis volume for its Sophia DDM genomic analysis software platform.
Sophia sponsored a meeting gathering early adopters, pharma partners, and others to discuss the recently launched MSK-ACCESS, and soon-to-launch MSK-IMPACT kits.
In Brief This Week: Agilent, Thermo Fisher Scientific, Danaher, Sophia Genetics
News items for the week of Sept. 9, 2024.
360Dx Top 30 Ticks up 2 Percent in August
Of the 30 companies in the index, 17 saw their share price increase, 12 saw their stock price decline, and one remained flat month over month.
Sophia Genetics DDM Platform Gains CE Marking
The software informs drug discovery and development, as well as treatment decisions by analyzing genomics and other clinical data.
Aug 1, 2024
360Dx Top 30 Jumps 11 Percent in July
Mar 5, 2024
Sophia Genetics Q4 Revenues up 27 Percent
May 11, 2022
May 10, 2022